Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6527 USD | -4.62% | -22.69% | -44.69% |
Apr. 08 | Venus Concept Inc. Announces Israeli Regulatory Approval for Venus Bliss MAX | CI |
Apr. 01 | Transcript : Venus Concept Inc., Q4 2023 Earnings Call, Apr 01, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.69% | 4.35M | |
+8.71% | 219B | |
+7.32% | 183B | |
+11.26% | 133B | |
+25.51% | 108B | |
+0.80% | 63.06B | |
+12.77% | 52.02B | |
-0.62% | 48.2B | |
-0.06% | 40.37B | |
+13.24% | 39.35B |
- Stock Market
- Equities
- VERO Stock
- News Venus Concept Inc.
- Venus Concept Receives FDA Clearance for Venus Versa Pro System